These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36972380)

  • 1. Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.
    Chaganti J; Zeng G; Tun N; Lockart I; Abdelshaheed C; Cysique L; Montagnese S; Brew BJ; Danta M
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
    Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
    J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes.
    Oeltzschner G; Butz M; Wickrath F; Wittsack HJ; Schnitzler A
    Metab Brain Dis; 2016 Jun; 31(3):517-27. PubMed ID: 26563124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbance of thalamic metabolism and its association with regional neural dysfunction and cognitive impairment in minimal hepatic encephalopathy.
    Chen LH; Shi JY; Zou TX; Zhang L; Gou Y; Lin Y; Chen HJ
    Eur J Radiol; 2020 Oct; 131():109252. PubMed ID: 32949859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis.
    Tran TT; Wei K; Cole S; Mena E; Csete M; King KS
    J Neuroimaging; 2020 Sep; 30(5):697-703. PubMed ID: 32705733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes.
    Oeltzschner G; Butz M; Baumgarten TJ; Hoogenboom N; Wittsack HJ; Schnitzler A
    Metab Brain Dis; 2015 Dec; 30(6):1429-38. PubMed ID: 26359122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.
    Razek AA; Abdalla A; Ezzat A; Megahed A; Barakat T
    Neuroradiology; 2014 Oct; 56(10):885-91. PubMed ID: 25060166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.
    Naegele T; Grodd W; Viebahn R; Seeger U; Klose U; Seitz D; Kaiser S; Mader I; Mayer J; Lauchart W; Gregor M; Voigt K
    Radiology; 2000 Sep; 216(3):683-91. PubMed ID: 10966695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J-difference GABA-edited MRS reveals altered cerebello-thalamo-cortical metabolism in patients with hepatic encephalopathy.
    Zöllner HJ; Thiel TA; Füllenbach ND; Jördens MS; Ahn S; Wilms LM; Ljimani A; Häussinger D; Butz M; Wittsack HJ; Schnitzler A; Oeltzschner G
    Metab Brain Dis; 2023 Apr; 38(4):1221-1238. PubMed ID: 36729261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of
    Boruah DK; Marak R; Bhuyan D; Mazumdar H; Patgiri SJ
    J Neurosci Rural Pract; 2024; 15(2):245-254. PubMed ID: 38746531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy.
    Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M
    Neurology; 2020 Mar; 94(11):e1147-e1156. PubMed ID: 31919113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
    Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic disorder and functional disturbance in the central executive network in minimal hepatic encephalopathy.
    Dong QY; Cao YB; Huang HW; Li D; Lin Y; Chen HJ
    Cereb Cortex; 2024 Jan; 34(2):. PubMed ID: 38365269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cognitive control network is related to psychometric and biochemical profiles in covert hepatic encephalopathy.
    Tsai CF; Tu PC; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Liu PY; Lu CL
    Sci Rep; 2019 Apr; 9(1):6580. PubMed ID: 31036843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.